SCHEMBL11374236

SCHEMBL11374236

CCc1ccc2ccnc(N)c2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.45
▸ NOS2 P35228 6/20 0.43
▸ NOS3 P29474 5/20 0.43
▸ MAP4K4 O95819 1/20 0.41
▸ TLR8 Q9NR97 2/20 0.38
▸ NOS1 P29475 2/20 0.37
▸ F12 P00748 1/20 0.37
▸ PLAU P00749 1/20 0.37
▸ NCF1 P14598 1/20 0.37
▸ BACE1 P56817 1/20 0.37
▸ CCR1 P32246 2/20 0.36
▸ PRKCI P41743 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA2B P29275 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ DHFR P00374 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ ROCK1 Q13464 1/20 0.35
▸ LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833379 0.77 CCR1 (0.56) PARP1NOS2NOS3CCR1DHFR
SCHEMBL15581732 0.77 CCR1 (0.56) PARP1NOS2NOS3CCR1DHFR
SCHEMBL11366326 0.77 TLR7 (0.43) NOS2NOS3TLR8DHFRROCK1
SCHEMBL11376008 0.76 ROCK1 (0.41) NOS2NOS3TLR8NOS1F12
SCHEMBL8669652 0.75 PDE10A (0.40) PARP1CCR1RPS6KA5
SCHEMBL11370420 0.75 DHFR (0.56) TLR8NOS1BACE1DHFRROCK1
SCHEMBL11370503 0.75 TLR8 (0.46) NOS2NOS3MAP4K4TLR8NOS1
SCHEMBL11375597 0.75 CCR1 (0.56) PARP1NOS2NOS3MAP4K4NOS1
SCHEMBL11377589 0.74 ALDH1A1 (0.49) TLR8DHFRPOLBROCK1LMNA
SCHEMBL11368123 0.74 HSP90AB1 (0.46) MAP4K4DHFRPOLBROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827634-B2 Small molecule inhibitors of NF-kB inducing kinase JANSSEN PHARMACEUTICA NV (BE) 2023-11-28 — — US disclosed
US-11254673-B2 Small molecule inhibitors of NF-κB inducing kinase JANSSEN PHARMACEUTICA NV (BE) 2022-02-22 — — US disclosed
US-20210300918-A1 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2021-09-30 — — US disclosed
US-4260759-A CONDENSATION OF NITRILES SCHERING-CORPORATION (US) 1981-04-07 — — US disclosed
US-4115395-A FUNGICIDES, BACTERICIDES SCHERING CORPORATION (US) 1978-09-19 — — US disclosed
US-4107166-A ANTIFUNGAL, ANTIBACTERIAL SCHERING CORPORATION (US) 1978-08-15 — — US disclosed
US-4017500-A FUNGICIDES, BACTERICIDES SCHERING CORPORATION (US) 1977-04-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300918-A1 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE NFKBIA, IKBKB, NFRKB PARP1 944/4885NOS2 853/4885NOS3 1444/4885
US-11827634-B2 Small molecule inhibitors of NF-kB inducing kinase NFKBIA, IKBKB, NFRKB PARP1 944/4885NOS2 853/4885NOS3 1444/4885
US-11254673-B2 Small molecule inhibitors of NF-κB inducing kinase NFKBIA, IKBKB, CHUK PARP1 920/4885NOS2 890/4885NOS3 1372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback